Atherosclerosis

Papers
(The TQCC of Atherosclerosis is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-02-01 to 2024-02-01.)
ArticleCitations
Endothelial dysfunction in COVID-19: Current findings and therapeutic implications187
Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM112
Calcium deposition within coronary atherosclerotic lesion: Implications for plaque stability85
Platelet-leukocyte interplay during vascular disease79
Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study76
Insights into the regulatory role of circRNA in angiogenesis and clinical implications74
A link between inflammation and thrombosis in atherosclerotic cardiovascular diseases: Clinical and therapeutic implications73
Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force73
Systemic immune-inflammation index and incident cardiovascular diseases among middle-aged and elderly Chinese adults: The Dongfeng-Tongji cohort study66
Performance of a deep learning algorithm for the evaluation of CAD-RADS classification with CCTA61
Targeting HDAC6 attenuates nicotine-induced macrophage pyroptosis via NF-κB/NLRP3 pathway61
High density lipoprotein functionality and cardiovascular events and mortality: A systematic review and meta-analysis59
EPA and DHA differentially modulate monocyte inflammatory response in subjects with chronic inflammation in part via plasma specialized pro-resolving lipid mediators: A randomized, double-blind, cross59
APOE gene variants in primary dyslipidemia56
Lipoprotein(a) beyond the kringle IV repeat polymorphism: The complexity of genetic variation in the LPA gene53
Lipoprotein(a) and cardiovascular and valvular diseases: A genetic epidemiological perspective51
Epicardial fat and coronary artery disease: Role of cardiac imaging51
Managing hyperlipidaemia in patients with COVID-19 and during its pandemic: An expert panel position statement from HEART UK50
The dedicated “Lp(a) clinic”: A concept whose time has arrived?48
Tissue factor in atherosclerosis and atherothrombosis47
Apolipoprotein A-I concentrations and risk of coronary artery disease: A Mendelian randomization study45
Carotid intima-media thickness should not be referred to as subclinical atherosclerosis: A recommended update to the editorial policy at Atherosclerosis45
Platelets as therapeutic targets to prevent atherosclerosis45
Transendothelial transport of lipoproteins44
Combination of bempedoic acid, ezetimibe, and atorvastatin in patients with hypercholesterolemia: A randomized clinical trial43
The accuracy of toe brachial index and ankle brachial index in the diagnosis of lower limb peripheral arterial disease: A systematic review and meta-analysis41
Shift work, and particularly permanent night shifts, promote dyslipidaemia: A systematic review and meta-analysis40
Association between liver fibrosis scores and the risk of mortality among patients with coronary artery disease39
Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors39
Lipoprotein(a) measurement issues: Are we making a mountain out of a molehill?39
All-cause and cause-specific mortality in individuals with zero and minimal coronary artery calcium: A long-term, competing risk analysis in the Coronary Artery Calcium Consortium39
Innate and adaptive immunity in cardiovascular calcification39
Circulating ceramides as biomarkers of cardiovascular disease: Evidence from phenotypic and genomic studies38
TRPA1 regulates macrophages phenotype plasticity and atherosclerosis progression37
Prognostic value of coronary artery calcium score, area, and density among individuals on statin therapy vs. non-users: The coronary artery calcium consortium37
HDAC3 protects against atherosclerosis through inhibition of inflammation via the microRNA-19b/PPARγ/NF-κB axis36
South Asian ethnicity as a risk factor for coronary heart disease35
atherosclerosis: gone with the Wnt?35
Existing and emerging strategies to lower Lipoprotein(a)35
Cardiac outcomes in patients with acute coronary syndrome attributable to calcified nodule35
Lipoprotein(a) levels from childhood to adulthood: Data in nearly 3,000 children who visited a pediatric lipid clinic34
Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: Many happy returns on investment?34
The impact of helical flow on coronary atherosclerotic plaque development34
Association of diabetes with outcomes in patients undergoing contemporary percutaneous coronary intervention: Pre-specified subgroup analysis from the randomized GLOBAL LEADERS study34
Statin use and mortality in COVID-19 patients: Updated systematic review and meta-analysis33
Marked plaque regression in homozygous familial hypercholesterolemia33
Non-genetic influences on lipoprotein(a) concentrations33
New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention?33
Coronavirus disease-19: The multi-level, multi-faceted vasculopathy32
Multifaceted role of extracellular vesicles in atherosclerosis32
Enhanced single-cell RNA-seq workflow reveals coronary artery disease cellular cross-talk and candidate drug targets31
Machine learning integration of circulating and imaging biomarkers for explainable patient-specific prediction of cardiac events: A prospective study31
Brain-heart connections in stress and cardiovascular disease: Implications for the cardiac patient31
Electronic cigarettes containing nicotine increase endothelial and platelet derived extracellular vesicles in healthy volunteers30
Lipoprotein(a): An underestimated inflammatory mastermind30
Cardiovascular events and the role of accelerated atherosclerosis in systemic vasculitis30
Oxidized phospholipid modification of lipoprotein(a): Epidemiology, biochemistry and pathophysiology29
Association of variability in uric acid and future clinical outcomes of patient with coronary artery disease undergoing percutaneous coronary intervention28
Association of NPAC score with survival after acute myocardial infarction28
Molecular mechanism for nobiletin to enhance ABCA1/G1 expression in mouse macrophages28
Innate and adaptive immune cell subsets as risk factors for coronary heart disease in two population-based cohorts28
SAFEHEART risk-equation and cholesterol-year-score are powerful predictors of cardiovascular events in French patients with familial hypercholesterolemia28
Fetal toxicity associated with statins: A systematic review and meta-analysis27
Impact of SARS-CoV-2 positivity on clinical outcome among STEMI patients undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registry27
Prognostic impact of healed coronary plaque in non-culprit lesions assessed by optical coherence tomography27
Coronary provocative tests in the catheterization laboratory: Pathophysiological bases, methodological considerations and clinical implications27
Beyond fibrinolysis: The confounding role of Lp(a) in thrombosis27
Physical activity and exercise improve retinal microvascular health as a biomarker of cardiovascular risk: A systematic review27
Sex-specific predictors of PCSK9 levels in a European population: The IMPROVE study27
A randomized study investigating the safety, tolerability, and pharmacokinetics of evinacumab, an ANGPTL3 inhibitor, in healthy Japanese and Caucasian subjects27
Association of body weight gain with subsequent cardiovascular event in non-obese general population without overt cardiovascular disease27
Pre-clinical assessment of SLN360, a novel siRNA targeting LPA, developed to address elevated lipoprotein (a) in cardiovascular disease26
Endothelial dysfunction and arterial stiffness in patients with systemic lupus erythematosus: A systematic review and meta-analysis26
Associations of serum uric acid with total and cause-specific mortality: Findings from individuals and pooling prospective studies26
The multifaceted impact of complement on atherosclerosis26
Association of beta-2-microglobulin and cardiovascular events and mortality: A systematic review and meta-analysis26
Lipoprotein(a) and ethnicities25
Familial hypercholesterolaemia and COVID-19: A two-hit scenario for endothelial dysfunction amenable to treatment25
The position of functional foods and supplements with a serum LDL-C lowering effect in the spectrum ranging from universal to care-related CVD risk management25
Chronic kidney disease and outcomes of lower extremity revascularization for peripheral artery disease25
Association of blood lipid profile with incident chronic kidney disease: A Mendelian randomization study25
Alirocumab treatment and neurocognitive function according to the CANTAB scale in patients at increased cardiovascular risk: A prospective, randomized, placebo-controlled study25
Lipid-lowering therapy use in primary and secondary care in Central and Eastern Europe: DA VINCI observational study24
Recent advances in demystifying the metabolism of lipoprotein(a)24
Lipoprotein (a) and diabetes mellitus24
Omega-3 fatty acids ameliorate vascular inflammation: A rationale for their atheroprotective effects24
Lipoprotein(a), venous thromboembolism and COVID-19: A pilot study24
Impact of clinical and subclinical coronary artery disease as assessed by coronary artery calcium in COVID-1924
Long noncoding RNA XXYLT1-AS2 regulates proliferation and adhesion by targeting the RNA binding protein FUS in HUVEC24
Fasting plasma glucose and subsequent cardiovascular disease among young adults: Analysis of a nationwide epidemiological database23
Effects of resistance training on endothelial function: A systematic review and meta-analysis23
The relation between healthy lifestyle changes and decrease in systemic inflammation in patients with stable cardiovascular disease23
Additive contribution of microRNA-34a/b/c to human arterial ageing and atherosclerosis23
Colchicine reduces extracellular vesicle NLRP3 inflammasome protein levels in chronic coronary disease: A LoDoCo2 biomarker substudy23
The multifaceted contribution of platelets in the emergence and aftermath of acute cardiovascular events23
Irisin alleviates vascular calcification by inhibiting VSMC osteoblastic transformation and mitochondria dysfunction via AMPK/Drp1 signaling pathway in chronic kidney disease23
Effect of Coenzyme Q10 on statin-associated myalgia and adherence to statin therapy: A systematic review and meta-analysis22
Natural compounds as anti-atherogenic agents: Clinical evidence for improved cardiovascular outcomes22
Risk of myocardial infarction based on endothelial shear stress analysis using coronary angiography22
Targeting the chemokine network in atherosclerosis22
The emerging landscape of peptide-based inhibitors of PCSK922
Is protein the forgotten ingredient: Effects of higher compared to lower protein diets on cardiometabolic risk factors. A systematic review and meta-analysis of randomised controlled trials22
Lipid levels, atrial fibrillation and the impact of age: Results from the LIPIDOGRAM2015 study21
New insights into endogenous mechanisms of protection against arterial calcification21
Blood urea nitrogen, blood urea nitrogen to creatinine ratio and incident stroke: The Dongfeng-Tongji cohort21
Photon-counting CT with tungsten as contrast medium: Experimental evidence of vessel lumen and plaque visualization21
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features21
Vascular imaging of atherosclerosis: Strengths and weaknesses21
No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels21
Sex differences of lipoprotein(a) levels and associated risk of morbidity and mortality by age: The Copenhagen General Population Study21
Is periodontitis a risk factor for ischaemic stroke, coronary artery disease and subclinical atherosclerosis? A Mendelian randomization study21
A systematic review and meta-analysis on the effects of statins on pregnancy outcomes21
Blocking the NLRP3 inflammasome reduces osteogenic calcification and M1 macrophage polarization in a mouse model of calcified aortic valve stenosis21
Associations between plasma ceramides and mortality in patients with coronary artery disease21
Role of mechanical stress and neutrophils in the pathogenesis of plaque erosion21
Retinal microvascular findings and risk of incident peripheral artery disease: An analysis from the Atherosclerosis Risk in Communities (ARIC) Study20
The relationship between cardiorespiratory fitness, cardiovascular risk factors and atherosclerosis20
Loss of statin treatment years during pregnancy and breastfeeding periods in women with familial hypercholesterolemia20
International Union of Angiology (IUA) consensus paper on imaging strategies in atherosclerotic carotid artery imaging: From basic strategies to advanced approaches20
Associations between particulate matter air pollution, presence and progression of subclinical coronary and carotid atherosclerosis: A systematic review20
Intravascular ultrasound-based deep learning for plaque characterization in coronary artery disease20
Lipoprotein(a) levels and atherosclerotic plaque characteristics in the carotid artery: The Plaque at RISK (PARISK) study20
Angiopoietin-like protein 8 accelerates atherosclerosis in ApoE−/− mice19
Hsa-miR-140-5p down-regulates LDL receptor and attenuates LDL-C uptake in human hepatocytes19
Lipid-lowering therapies: Better together19
Practice of lipoprotein apheresis and short-term efficacy in children with homozygous familial hypercholesterolemia: Data from an international registry19
Macrophage infiltrates in coronary plaque erosion and cardiovascular outcome in patients with acute coronary syndrome19
Phenylacetylglutamine is associated with the degree of coronary atherosclerotic severity assessed by coronary computed tomographic angiography in patients with suspected coronary artery disease19
Advanced fibrosis of non-alcoholic steatohepatitis affects the significance of lipoprotein(a) as a cardiovascular risk factor19
Actin remodelling of the endothelium during transendothelial migration of leukocytes19
Inferior control of low-density lipoprotein cholesterol in women is the primary sex difference in modifiable cardiovascular risk: A large-scale, cross-sectional study in primary care19
Macrophage polarisation associated with atherosclerosis differentially affects their capacity to handle lipids19
Predictors of coronary artery calcium among 20-30-year-olds: The Coronary Artery Calcium Consortium19
Exploring the relationship between biomechanical stresses and coronary atherosclerosis19
Sex differences in impact of long-term burden and trends of body mass index and blood pressure from childhood to adulthood on arterial stiffness in adults: A 30-year cohort study19
DA VINCI study: Change in approach to cholesterol management will be needed to reduce the implementation gap between guidelines and clinical practice in Europe19
The PGC-1α/NRF1/miR-378a axis protects vascular smooth muscle cells from FFA-induced proliferation, migration and inflammation in atherosclerosis19
Elevated lipoprotein(a) in mitral and aortic valve calcification and disease: The Copenhagen General Population Study19
Wall shear stress estimated by 3D-QCA can predict cardiovascular events in lesions with borderline negative fractional flow reserve18
Effects of proprotein convertase subtilisin kexin type 9 modulation in human pancreatic beta cells function18
Hyperlipidemia does not affect development of elastase-induced abdominal aortic aneurysm in mice18
Prevalence and influence of LPA gene variants and isoform size on the Lp(a)-lowering effect of pelacarsen18
Extracellular vesicles in atherothrombosis and cardiovascular disease: Friends and foes18
Platelet “-omics” in health and cardiovascular disease18
Lifestyle intervention using mobile technology and smart devices in patients with high cardiovascular risk: A pragmatic randomised clinical trial18
Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society18
Mitochondria-targeted esculetin mitigates atherosclerosis in the setting of aging via the modulation of SIRT1-mediated vascular cell senescence and mitochondrial function in Apoe mice18
Human apolipoprotein A-II reduces atherosclerosis in knock-in rabbits18
A meta-analysis of medications directed against PCSK9 in familial hypercholesterolemia18
IMT is not atherosclerosis18
Role of ADAM9 and miR-126 in the development of abdominal aortic aneurysm18
The plasma protein profile and cardiovascular risk differ between intima-media thickness of the common carotid artery and the bulb: A meta-analysis and a longitudinal evaluation17
How strong is the evidence that gut microbiota composition can be influenced by lifestyle interventions in a cardio-protective way?17
Sex differences in cardiovascular morbidity associated with familial hypercholesterolaemia: A retrospective cohort study of the UK Simon Broome register linked to national hospital records17
Association of plasma trimethylamine N-oxide levels with atherosclerotic cardiovascular disease and factors of the metabolic syndrome17
Statin therapy for the primary prevention of cardiovascular disease: Pros17
Polyvascular disease: A narrative review of current evidence and a consideration of the role of antithrombotic therapy17
MDM2 contributes to oxidized low-density lipoprotein-induced inflammation through modulation of mitochondrial damage in endothelial cells17
The effect of transgender hormonal treatment on high density lipoprotein cholesterol efflux capacity17
Cardiovascular effects of omega-3 fatty acids: Hope or hype?17
The association of serum lipid and lipoprotein levels with total and differential leukocyte counts: Results of a cross-sectional and longitudinal analysis of the UK Biobank17
The long journey of lipoprotein(a) from cardiovascular curiosity to therapeutic target17
Relationship of fibroblast growth factor 21 levels with inflammation, lipoproteins and non-alcoholic fatty liver disease16
Targeting the phenotypic switch of vascular smooth muscle cells to tackle atherosclerosis16
Mid-term predictive value of calciprotein particles in maintenance hemodialysis patients based on a gel-filtration assay16
Targeting vascular smooth muscle cell dysfunction with xanthine derivative KMUP-3 inhibits abdominal aortic aneurysm in mice16
Estimation of the major cardiovascular events prevention with Inclisiran16
Internalization of microparticles by platelets is partially mediated by toll-like receptor 4 and enhances platelet thrombogenicity16
Role of mitochondrial DNA copy number in incident cardiovascular diseases and the association between cardiovascular disease and type 2 diabetes: A follow-up study on middle-aged women16
Mendelian Randomization: Principles and its usage in Lp(a) research16
Impact of air pollution on ischemic heart disease: Evidence, mechanisms, clinical perspectives16
Does variation in serum LDL-cholesterol response to dietary fatty acids help explain the controversy over fat quality and cardiovascular disease risk?16
Hyperinsulinemia promotes endothelial inflammation via increased expression and release of Angiopoietin-216
Comparison of the mutation spectrum and association with pre and post treatment lipid measures of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries16
Low muscle mass is associated with carotid atherosclerosis in patients with type 2 diabetes16
Chronic kidney disease measures for cardiovascular risk prediction16
A phase 2 trial of the efficacy and safety of evinacumab in patients with severe hypertriglyceridemia16
Single cell analyses to understand the immune continuum in atherosclerosis16
Coronary artery calcium scores indicating secondary prevention level risk: Findings from the CAC consortium and FOURIER trial15
Polygenic risk score and coronary artery disease: A meta-analysis of 979,286 participant data15
Molecular genetic testing for autosomal dominant hypercholesterolemia in 29,449 Norwegian index patients and 14,230 relatives during the years 1993–202015
l-Arginine prevents inflammatory and pro-calcific differentiation of interstitial aortic valve cells15
Role of RhoA and Rho-associated kinase in phenotypic switching of vascular smooth muscle cells: Implications for vascular function15
The association between plasma proteomics and incident cardiovascular disease identifies MMP-12 as a promising cardiovascular risk marker in patients with chronic kidney disease15
Exploring the causal pathway from bilirubin to CVD and diabetes in the UK biobank cohort study: Observational findings and Mendelian randomization studies15
Genotype-phenotype correlation in pseudoxanthoma elasticum15
Regression in carotid plaque lipid content and neovasculature with PCSK9 inhibition: A time course study15
2.5-fold increased risk of recurrent acute myocardial infarction with familial hypercholesterolemia15
Long noncoding RNA ZNF800 suppresses proliferation and migration of vascular smooth muscle cells by upregulating PTEN and inhibiting AKT/mTOR/HIF-1α signaling15
Lipoprotein (a) and aortic valve calcium in South Asians compared to other race/ethnic groups15
Genetics of adrenergic signaling drives coronary artery calcification15
Sex related differences in therapy and outcome of patients with intermittent claudication in a real-world cohort15
Heightened splenic and bone marrow uptake of 18F-FDG PET/CT is associated with systemic inflammation and subclinical atherosclerosis by CCTA in psoriasis: An observational study15
Visit-to-visit variability of lipid measurements and the risk of myocardial infarction and all-cause mortality: A prospective cohort study15
The important role of histone deacetylases in modulating vascular physiology and arteriosclerosis15
Dietary sucrose induces metabolic inflammation and atherosclerotic cardiovascular diseases more than dietary fat in LDLr ApoB100/100 mice14
Oxidized low-density lipoprotein (LDL) and LDL cholesterol are associated with outcomes of minor stroke and TIA14
PCSK9 promotes arterial medial calcification14
Risk-factors associated with extremely high cardiovascular risk of mid- and long-term mortality following myocardial infarction: Analysis of the Hyperlipidaemia Therapy in tERtiary Cardiological cEnTe14
Endothelial glycocalyx and severity and vulnerability of coronary plaque in patients with coronary artery disease14
Added value of high-risk plaque criteria by coronary CTA for prediction of long-term outcomes14
Carotid plaque is strongly associated with coronary artery calcium and predicts incident coronary heart disease in a population-based cohort14
Baseline or 90-day fibrinogen levels and long-term outcomes after ischemic stroke or TIA: Results from the China national stroke registry Ⅲ14
Preclinical atherosclerosis and cardiovascular events: Do we have a consensus about the role of preclinical atherosclerosis in the prediction of cardiovascular events?14
Endothelial cells exposed to atheroprotective flow secrete follistatin-like 1 protein which reduces transcytosis and inflammation14
Free cholesterol, cholesterol precursor and plant sterol levels in atherosclerotic plaques are independently associated with symptomatic advanced carotid artery stenosis14
Serum lipoprotein(a) levels and insulin resistance have opposite effects on fatty liver disease14
The age- and sex-specific composition of atherosclerotic plaques in vascular surgery patients14
Hypoxia inducible factor 1α inhibitor PX-478 reduces atherosclerosis in mice14
Cumulative dyslipidemia with arterial stiffness and carotid IMT progression in asymptomatic adolescents: A simulated intervention longitudinal study using temporal inverse allocation model14
The regulation of Ero1-alpha in homocysteine-induced macrophage apoptosis and vulnerable plaque formation in atherosclerosis14
Carotid intima-media thickness and subclinical left heart dysfunction in the general population14
Elevated levels of serum PCSK9 in male patients with symptomatic peripheral artery disease: The CAVASIC study14
Acute ischemic stroke versus transient ischemic attack: Differential plaque morphological features in symptomatic intracranial atherosclerotic lesions14
Methodological issues regarding: “A third of nonfasting plasma cholesterol is in remnant lipoproteins: Lipoprotein subclass profiling in 9293 individuals”13
Regulation of intestinal LDLR by the LXR-IDOL axis13
Transcriptome analysis revealed a two-step transformation of vascular smooth muscle cells to macrophage-like cells13
Serum uromodulin and risk for cardiovascular morbidity and mortality in the community-based KORA F4 study13
CREB/ATF3 signaling mediates indoxyl sulfate-induced vascular smooth muscle cell proliferation and neointimal formation in uremia13
Aortic valve calcification predicts all-cause mortality independent of coronary calcification and severe stenosis13
Is estimated cardiorespiratory fitness an effective predictor for cardiovascular and all-cause mortality? A meta-analysis13
Macrophage metabolic regulation in atherosclerotic plaque13
Association of circulating branched-chain amino acids with risk of cardiovascular disease: A systematic review and meta-analysis13
Progression of valvular calcification and risk of incident stroke: The Multi-Ethnic Study of Atherosclerosis (MESA)13
Quantitative evaluation of statin effectiveness versus intolerance and strategies for management of intolerance13
Predictors of coronary artery calcium incidence and progression: The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)13
Relationship between elevated plasma ceramides and plaque rupture in patients with ST-segment elevation myocardial infarction13
An age-matched computed tomography angiographic study of coronary atherosclerotic plaques in patients with familial hypercholesterolaemia13
High levels of eicosapentaenoic acid are associated with lower pericoronary adipose tissue attenuation as measured by coronary CTA13
Coronary plaque burden, plaque characterization and their prognostic implications in familial hypercholesterolemia: A computed tomographic angiography study13
Long-term persistence with evolocumab treatment and sustained reductions in LDL-cholesterol levels over 30 months: Final results from the European observational HEYMANS study13
Possible association between eating behaviors and cardiovascular disease in the general population: Analysis of a nationwide epidemiological database13
Should we target increased physical activity or less sedentary behavior in the battle against cardiovascular disease risk development?13
Cholesterol crystals drive metabolic reprogramming and M1 macrophage polarisation in primary human macrophages13
High lipoprotein(a) is associated with major adverse limb events after femoral artery endarterectomy13
Hyperuricemia precedes non-alcoholic fatty liver disease with abdominal obesity moderating this unidirectional relationship: Three longitudinal analyses13
Association between serum glycated albumin and risk of cardiovascular disease in a Japanese community: The Hisayama Study12
New prediction tools and treatment for ACS patients with plaque erosion12
Characteristics of atherosclerosis in femoropopliteal artery and its clinical relevance12
The LDL-C/ApoB ratio predicts major cardiovascular events in patients with established atherosclerotic cardiovascular disease12
LIPA gene mutations affect the composition of lipoproteins: Enrichment in ACAT-derived cholesteryl esters12
The C57Bl/6J mouse strain is more susceptible to angiotensin II-induced aortic aneurysm formation than C57Bl/6N12
Complementary roles of platelet αIIbβ3 integrin, phosphatidylserine exposure and cytoskeletal rearrangement in the release of extracellular vesicles12
Semaglutide reduces vascular inflammation investigated by PET in a rabbit model of advanced atherosclerosis12
Age- and sex-specific trends in the incidence of myocardial infarction in Denmark, 2005 to 202112
18Fluoride-based molecular imaging of coronary atherosclerosis in HIV infected patients12
The NO-donor MPC-1011 stimulates angiogenesis and arteriogenesis and improves hindlimb ischemia via a cGMP-dependent pathway involving VEGF and SDF-1α12
Association of plaque calcification pattern and attenuation with instability features and coronary stenosis and calcification grade12
The difference between cystatin C- and creatinine-based eGFR is associated with adverse cardiovascular outcome in patients with chronic kidney disease12
Risk of peripheral artery disease according to race and sex: The Atherosclerosis Risk in Communities (ARIC) study12
0.054974794387817